Metal ion contents of gel-filtered platelets from patients with storage pool disease.
Platelets from nine patients with storage pool disease (SPD) and from ten control subjects were isolated by gel filtration into a suspension medium permitting the direct determination of platelet Mg-2+, Ca-2+, and K+ levels. The total intracellular levels of ATP and ADP, as well as the incorporation patterns of 14-C-adenine into the metabolic nucleotide pool, were also determined in these platelet suspensions. The gel-filtered platelets (GFP) from SPD patients exhibited slightly lowered levels of ATP and substantially reduced amounts of ADP, in agreement with previous studies using PRP suspensions. Diminished aggregation responses to ADP, epinephrine, and to collagen in particular, similar to those observed previously in PRP, were obtained in GFP from SPD patients. However, GFP from the patients exhibited more variable aggregation responses to addition of ADP and epinephrine than did GFP from the control subjects. Increases in the extent of radioactive hypoxanthine formation, observed previously in normal platelets as a result of isolation into the suspension medium used in these studies, were significantly reduced in the GFP from SPD patients. The levels of platelet Mg-2+ and K+ determined in GFP from the patients were not significantly different from the levels of these ions in GFP from control subjects. However, substantial reductions in platelet Ca-2+ were found in the SPD platelets. A strong correlation was obtained between this reduction in platelet Ca-2+ and the reduction in ADP in these platelets. No such correlation was apparent between the ATP and Ca-2+ deficiencies. These results suggest that a major portion of platelet Ca-2+ may be located in the dense granules and support previous hypotheses that granular ADP and/or Ca-2+ may play a role in the release reaction. The finding of normal levels of platelet Mg-2+ and K+ in SPD platelets, however, suggests that these latter ions are not located in the dense granules.
D000225:Adenine / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000032:analysis / Q000172:deficiency; D000255:Adenosine Triphosphate / Q000032:analysis; D001791:Blood Platelet Disorders / Q000097:blood / Q000151:congenital; D001792:Blood Platelets / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis; D002118:Calcium / Q000097:blood* / Q000172:deficiency; D002250:Carbon Radioisotopes; D002850:Chromatography, Gel; D003094:Collagen / Q000494:pharmacology; D003594:Cytoplasmic Granules; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D007042:Hypoxanthines / Q000096:biosynthesis; D008274:Magnesium / Q000097:blood*; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D011188:Potassium / Q000097:blood*
D001798:Blood Proteins; D002250:Carbon Radioisotopes; D007042:Hypoxanthines; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D003094:Collagen; D008274:Magnesium; D000225:Adenine; D011188:Potassium; D002118:Calcium; D004837:Epinephrine